Grifols says due diligence done, Shanghai RAAS stake sale to go ahead
Grifols’ $1.8 billion sale of a 20% stake in Shanghai RAAS will proceed after a due diligence process concluded “satisfactorily”, the Spanish drug maker said on Friday.
Symbol | Last Price | Change | % Change |
---|---|---|---|